摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Amino-3-(4-methoxyphenyl)-2-methylprop-2-enenitrile | 1050392-15-8

中文名称
——
中文别名
——
英文名称
3-Amino-3-(4-methoxyphenyl)-2-methylprop-2-enenitrile
英文别名
——
3-Amino-3-(4-methoxyphenyl)-2-methylprop-2-enenitrile化学式
CAS
1050392-15-8
化学式
C11H12N2O
mdl
——
分子量
188.229
InChiKey
KDVPKCGRSDZCKH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    405.4±35.0 °C(Predicted)
  • 密度:
    1.099

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    59
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2926909090

SDS

SDS:7eede67c1277c2778f2b32843220aba9
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity
    摘要:
    The disclosed 3-phenyl-5-isothiazole carboxamides are potent allosteric antagonists of mGluR1 with generally good selectivity relative to the related group 1 receptor mGluR5. Pharmacokinetic properties of a member of this series (1R,2R)-N-(3-(4-methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropanecarboxamide (14) are good, showing acceptable plasma and brain exposure after oral dosing. Oral administration of isothiazole 14 gave robust activity in the formalin model of persistent pain which correlated with CNS receptor occupancy. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.02.003
  • 作为产物:
    参考文献:
    名称:
    3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity
    摘要:
    The disclosed 3-phenyl-5-isothiazole carboxamides are potent allosteric antagonists of mGluR1 with generally good selectivity relative to the related group 1 receptor mGluR5. Pharmacokinetic properties of a member of this series (1R,2R)-N-(3-(4-methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropanecarboxamide (14) are good, showing acceptable plasma and brain exposure after oral dosing. Oral administration of isothiazole 14 gave robust activity in the formalin model of persistent pain which correlated with CNS receptor occupancy. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.02.003
点击查看最新优质反应信息

文献信息

  • Substituted carboxamides
    申请人:Eli Lilly and Company
    公开号:US07960419B2
    公开(公告)日:2011-06-14
    This application relates to a substituted carboxamide compound of formula I, or a pharmaceutically acceptable salt thereof, as defined herein, a pharmaceutical composition thereof, and its use in treating pain.
    本申请涉及一种代替的羧酰胺化合物I式,或其在此定义下的药物可接受的盐,以及其制备的药物组合物,以及其在治疗疼痛中的应用。
  • SUBSTITUTED CARBOXAMIDES
    申请人:Backer Ryan Thomas
    公开号:US20090182025A1
    公开(公告)日:2009-07-16
    This application relates to a substituted carboxamide compound of formula I, or a pharmaceutically acceptable salt thereof, as defined herein, a pharmaceutical composition thereof, and its use in treating pain.
    本申请涉及一种公式I的取代羧酰胺化合物,或其在药学上可接受的盐,如本文中所定义的,以及其制备的药物组合物及其在治疗疼痛中的应用。
  • 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity
    作者:Matthew J. Fisher、Ryan T. Backer、Vanessa N. Barth、Kim E. Garbison、Joseph M. Gruber、Beverly A. Heinz、Smriti Iyengar、Sean P. Hollinshead、Anne Kingston、Steven L. Kuklish、Linglin Li、Eric S. Nisenbaum、Steven C. Peters、Lee Phebus、Rosa Maria A. Simmons、Ellen van der Aar
    DOI:10.1016/j.bmcl.2012.02.003
    日期:2012.4
    The disclosed 3-phenyl-5-isothiazole carboxamides are potent allosteric antagonists of mGluR1 with generally good selectivity relative to the related group 1 receptor mGluR5. Pharmacokinetic properties of a member of this series (1R,2R)-N-(3-(4-methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropanecarboxamide (14) are good, showing acceptable plasma and brain exposure after oral dosing. Oral administration of isothiazole 14 gave robust activity in the formalin model of persistent pain which correlated with CNS receptor occupancy. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多